Showing 271-280 of 2971 results for "".
MATV News: DREAM Initiative’s Forces of Beauty Report; AAFPRS Medical Mission Trip to Ukraine; Galderma’s Investigational Neurotoxin Gets High Marks
https://beta.modernaesthetics.com/series/matv-news/matv-news-dream-initiatives-forces-of-beauty-report-aafprs-medical-mission-trip-to-ukraine-galdermas-investigational-neurotoxin-gets-high-marks/33706/Allergan Aesthetics and skinbetter science have released a new report from their DREAM Initiative. The Forces of Beauty report provides a new understanding of what inclusive and representative beauty looks like today. Plastic surgeon Kelly Bolden, MD discusses the importance of the findings. AmericaMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://beta.modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News: Juvéderm Volux XC Approved; Joe Jonas and Xeomin Partner; Breast Implants Recipients Not Following Screening Guidelines
https://beta.modernaesthetics.com/series/matv-news/matv-news-juvederm-volux-xc-approved-joe-jonas-and-xeomin-partner-breast-implants-recipients-not-following-screening-guidelines/33701/Allergan Aesthetics wins FDA approval for Juvéderm Volux XC for the improvement of jawline definition in adults with moderate to severe loss of jawline definition; Pop icon Joe Jonas is the new brand partner for Merz Aesthetics’ Xeomin; and a new study finds silicone breast implant recipients may noMATV News: Promising Data for Galderma's RelabotulinumtoxinA; FDA Approves Sientra's New Breast Implant; Allergan Aesthetics Shares Global Trends Report
https://beta.modernaesthetics.com/series/matv-news/matv-news-promising-data-for-galdermas-relabotulinumtoxina-fda-approves-sientras-new-breast-implant-allergan-aesthetics-shares-global-trends-report/33697/Galderma's investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line Phase 3 data; and Sientra wins FDA approval for its Low Plus Profile ProMATV News: Dr. Jennifer Walden is First Female President of The Aesthetic Society; Plastic Surgeon Residents Face Childcare Issues; ASLMS President Outlines Goals
https://beta.modernaesthetics.com/series/matv-news/matv-news-dr-jennifer-walden-is-first-female-president-of-the-aesthetic-society-plastic-surgeon-residents-face-childcare-issues-aslms-president-outlines-goals/33685/Jennifer Walden, MD discusses her role and goals as the first female president of the Aesthetic Society; a new survey study finds plastic surgeon residents, especially women, face barriers accessing affordable childcare; and Paul Friedman, MD shares plans for his ASLMS presidency, including creatingMATV News Extra: The Lowdown on Allergan Alle Flash
https://beta.modernaesthetics.com/series/matv-news/matv-news-extra-the-lowdown-on-allergan-alle-flash/33682/Jasson Gilmore, Co-Founder of Allergan Data Labs, discusses the evolution of Allergan's Alle loyalty program and the launch of the Alle Flash. He shares insights on the benefits for patients and providers.MATV News: AIS Meeting Highlights; Benefits of Allergan Aesthetics’ Loyalty Program; A Lack of Diversity in Aesthetic Clinical Trials
https://beta.modernaesthetics.com/series/matv-news/matv-news-ais-meeting-highlights-benefits-of-allergan-aesthetics-loyalty-program-a-lack-of-diversity-in-aesthetic-clinical-trials/33671/Physician and industry experts share highlights from the Aesthetics Innovation Summit; Allergan Aesthetics enhances its loyalty program with the launch of Alle Flash; and a new study shows a lack of ethnic/racial diversity in industry-sponsored aesthetic trials.MATV News: New HA Fillers Show Promise; HydraFacial Launches Syndeo; AACS Names New President
https://beta.modernaesthetics.com/series/matv-news/matv-news-new-ha-fillers-show-promise-hydrofacial-launches-syndeo-aacs-names-new-president/33666/New HA fillers from Hallura show promise for lips, nasolabial folds, and cheeks. HydraFacial’s Syndeo aims to enhance the consumer and provider experience; and the American Academy of Cosmetic Surgery introduces J. Kevin Duplechain, MD as its new president.MATV News Extra: AAFPRS 2022 Outlook
https://beta.modernaesthetics.com/series/matv-news/matv-news-extra-aafprs-2022-outlook/33663/Corey S. Maas, MD, President of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), shares his goals for his leadership term. He also discusses the findings of the AAFPRS annual statistics and his insights about what’s driving the current surge in surgical and non-surgical aeMATV News: AAFPRS Annual Statistics; Merz Aesthetics Kicks of New Initiative; Juvéderm Volbella XC Wins Approval for Undereye Hollows
https://beta.modernaesthetics.com/series/matv-news/matv-news-aafprs-annual-statistics-merz-aesthetics-kicks-of-new-initiative-juvederm-volbella-xc-wins-approval-for-undereye-hollows/33662/AAFPRS President Corey S. Maas, MD discusses the association’s latest annual statistics and the surge in demand for facial plastic surgery in 2021; Merz Aesthetics kicks of a new initiative focused on what makes people feel confident; and the FDA approves Allergan Aesthetics’ Juvederm Volbella XC fo